Literature DB >> 15994835

Reduced mobilization of Rev-responsive element-deficient lentiviral vectors.

Susann Lucke1, Thomas Grunwald, Klaus Uberla.   

Abstract

Infection of cells transduced with a lentiviral vector by human immunodeficiency virus (HIV) could lead to packaging of the lentiviral vector RNA into HIV particles and unintended transfer of the vector. To prevent this, the Rev-responsive element (RRE) of an HIV-1 vector was functionally replaced by a heterologous RNA element (MS2). Providing Rev fused to an MS2 binding protein allowed efficient vector production. Mobilization of the vector from infected target cells was below the level of detection and at least 10(3)- to 10(4)-fold lower than for the RRE-containing vector. Thus, RRE-deficient lentiviral vectors provide a novel approach to reduce the risk of vector mobilization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994835      PMCID: PMC1168721          DOI: 10.1128/JVI.79.14.9359-9362.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

Review 1.  Retroviruses as model systems for the study of nuclear RNA export pathways.

Authors:  B R Cullen
Journal:  Virology       Date:  1998-09-30       Impact factor: 3.616

Review 2.  The HIV-1 Rev protein.

Authors:  V W Pollard; M H Malim
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

3.  HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.

Authors:  R A Fouchier; B E Meyer; J H Simon; U Fischer; M H Malim
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

4.  Development of a self-inactivating lentivirus vector.

Authors:  H Miyoshi; U Blömer; M Takahashi; F H Gage; I M Verma
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors.

Authors:  J C Johnston; M Gasmi; L E Lim; J H Elder; J K Yee; D J Jolly; K P Campbell; B L Davidson; S L Sauter
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

6.  Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors.

Authors:  E M Poeschla; F Wong-Staal; D J Looney
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

7.  Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: expression and potential for helper virus-free packaging.

Authors:  S K Arya; M Zamani; P Kundra
Journal:  Hum Gene Ther       Date:  1998-06-10       Impact factor: 5.695

8.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

9.  Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.

Authors:  R Zufferey; T Dull; R J Mandel; A Bukovsky; D Quiroz; L Naldini; D Trono
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.

Authors:  R I Connor; B K Chen; S Choe; N R Landau
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

View more
  11 in total

1.  Nuclear RNA export and packaging functions of HIV-1 Rev revisited.

Authors:  Maik Blissenbach; Bastian Grewe; Bianca Hoffmann; Sabine Brandt; Klaus Uberla
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

2.  Cytoplasmic utilization of human immunodeficiency virus type 1 genomic RNA is not dependent on a nuclear interaction with gag.

Authors:  Bastian Grewe; Bianca Hoffmann; Inga Ohs; Maik Blissenbach; Sabine Brandt; Bettina Tippler; Thomas Grunwald; Klaus Uberla
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

Review 3.  Gene delivery by lentivirus vectors.

Authors:  Adam S Cockrell; Tal Kafri
Journal:  Mol Biotechnol       Date:  2007-07       Impact factor: 2.860

4.  DDX1 is an RNA-dependent ATPase involved in HIV-1 Rev function and virus replication.

Authors:  Stephen P Edgcomb; Andrew B Carmel; Souad Naji; Geza Ambrus-Aikelin; Jason R Reyes; Andrew C S Saphire; Larry Gerace; James R Williamson
Journal:  J Mol Biol       Date:  2011-10-25       Impact factor: 5.469

5.  Rev proteins of human and simian immunodeficiency virus enhance RNA encapsidation.

Authors:  Sabine Brandt; Maik Blissenbach; Bastian Grewe; Rebecca Konietzny; Thomas Grunwald; Klaus Uberla
Journal:  PLoS Pathog       Date:  2007-04       Impact factor: 6.823

6.  A Rev-Independent gag/pol Eliminates Detectable psi-gag Recombination in Lentiviral Vectors.

Authors:  Semih U Tareen; Christopher J Nicolai; David J Campbell; Patrick A Flynn; Megan M Slough; Chintan D Vin; Brenna Kelley-Clarke; Jared M Odegard; Scott H Robbins
Journal:  Biores Open Access       Date:  2013-12-01

7.  Eliminating HIV-1 Packaging Sequences from Lentiviral Vector Proviruses Enhances Safety and Expedites Gene Transfer for Gene Therapy.

Authors:  Conrad A Vink; John R Counsell; Dany P Perocheau; Rajvinder Karda; Suzanne M K Buckley; Martijn H Brugman; Melanie Galla; Axel Schambach; Tristan R McKay; Simon N Waddington; Steven J Howe
Journal:  Mol Ther       Date:  2017-05-24       Impact factor: 11.454

8.  RRE-deleting self-inactivating and self-activating HIV-1 vectors for improved safety.

Authors:  Narasimhachar Srinivasakumar
Journal:  PeerJ       Date:  2013-06-04       Impact factor: 2.984

9.  The HIV-1 Rev protein enhances encapsidation of unspliced and spliced, RRE-containing lentiviral vector RNA.

Authors:  Bastian Grewe; Katrin Ehrhardt; Bianca Hoffmann; Maik Blissenbach; Sabine Brandt; Klaus Uberla
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

10.  Viral complementation allows HIV-1 replication without integration.

Authors:  Huub C Gelderblom; Dimitrios N Vatakis; Sean A Burke; Steven D Lawrie; Gregory C Bristol; David N Levy
Journal:  Retrovirology       Date:  2008-07-09       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.